HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bulgari fragrances

This article was originally published in The Rose Sheet

Executive Summary

Bulgari will end its 10-year marketing agreement with Fragrances Exclusive and internalize the management of its U.S. fragrance operations effective in January, the jeweler announces. Bulgari Corporation of America will manage all sales, marketing and financial operations formerly handled by Fragrances Exclusive as part of Bulgari's long-term growth strategy in the U.S., which includes significant strengthening of its internal structure, the company states. Bulgari fragrances have been marketed, sold and distributed by Fragrances Exclusive since 1994; the Chanel division has launched scents like Eau Parfumee au Thé Vert, Pour Femme, Pour Homme, Blu, Blu Pour Homme and Omnia...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012126

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel